Welcome to our dedicated page for BlackRock Tech and Private Equity Term SEC filings (Ticker: BTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Brooklyn is focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. The company is also exploring opportunities to advance therapies using leading edge gene editing/cell therapy technology through its option agreements with Factor Bioscience and Novellus. Brooklyn’s most advanced program is studying the safety and efficacy of IRX-2 in patients with head and neck cancer. In a Phase 2A clinical trial in head and neck cancer, IRX-2 demonstrated an overall survival benefit. Additional studies are either underway or planned in other solid tumor cancer indications.Key take-away: A Schedule 4 filing shows that Saba Capital Management, L.P. and its founder Boaz Weinstein – previously 10 % owners of BlackRock Technology & Private Equity Term Trust (ticker BTX) – tendered 60,675,395 common shares to the issuer on 07/09/2025 under the fund’s tender-offer programme (transaction code J).
The shares were disposed of at a stated price of $7.49 per share. After the transaction, the reporting parties list 0 shares beneficially owned, signalling a complete exit from their prior position. Because the sellers had been classified as 10 % beneficial owners, the move materially changes BTX’s ownership structure and removes an activist-oriented shareholder from the register.
Section 16 requires prompt disclosure when insiders or 10 % holders change their stakes. Investors may interpret the filing as (1) confirmation that the tender offer successfully repurchased a large block and (2) a potential shift in future governance dynamics, given Saba’s historic involvement in closed-end fund activism. No derivative positions were reported in Table II.
FAQ
What is the current stock price of BlackRock Tech and Private Equity Term (BTX)?
What is the market cap of BlackRock Tech and Private Equity Term (BTX)?
